Browse result page of THPdb

The total number entries retrieved from this search are 159

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
1400	Th1064	Muromonab	Heavy Chain: QVQLQQS Full view	664	IIa	Immunological	ORTHOCLONE OKT3 STERILE SOLUTION	Centocor Ortho Biotech, L.P.	Sterile Solution is a murine monoclonal antibody to the CD3 antigen of human T cells which functions as an immunosuppressant.	For Intravenous Use Only	Immunologic Factors and Immunosuppressive Agents	N.A.
1406	Th1066	Ibritumomab	Heavy Chain: QAYLQQS Full view	652	IIb	Cancer	Zevalin	Spectrum Pharmaceuticals	Clear, colorless, sterile, pyrogen-free, preservative-free solution that may contain translucent particles.	Intravenous infusion	N.A.	Digoxin
1412	Th1068	Tositumomab	Heavy Chain 1: QAYLQ Full view	1351	IIb	Cancer	Bexxar	Galaxo Smith Kline	Sterile, pyrogen-free, clear to opalescent, colorless to slightly yellow, preservative-free solutionÂÂÂ	Intravenous(IV) administration	N.A.	Bacterial outer membrane,Lipoteichoic acid synthesis
1431	Th1073	Alemtuzumab	Heavy Chain 1: QVQLQ Full view	2839	IIa	Cancer	CAMPATH	Genzyme Corporation	Sterile, clear, colorless, isotonic solution (pH 6.8-7.4)	Intravenous infusion	N.A.	N.A.
1432	Th1073	Alemtuzumab	Heavy Chain 1: QVQLQ Full view	2389	IIa	Cancer	LEMTRADA	Genzyme Corporation	LEMTRADA is a sterile, clear and colorless to slightly yellow, solution (pH 7.2±0.2) for infusion.	Intravenous infusion	NA	NA
1434	Th1074	Alglucerase	ARPCIPKSFGYSSVVCVCNA Full view	497	Ia	Metabolic	Ceredase	Genzyme Corporation	Clear sterile non-pyrogenic solution of alglucerase in a citrate buffered solution	Intravenous injection	Enzyme Replacement Agents	Plasminogen,Proteinase-activated receptor 1
1435	Th1075	Capromab	N.A. Full view	0	IV	Cancer	ProstaScint	Jazz Pharmaceuticals, Inc.	Sterile, pyrogen-free, clear, colorless solution that may contain some translucent particles.	Intravenous injection	Indicators, Reagents and Diagnostic Agents	CAMPATH-1 antigen,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
1437	Th1076	Laronidase	APHLVQVDAARALWPLRRFW Full view	626	Ia	Metabolic	ALDURAZYME	Genzyme Corporation	Sterile, nonpyrogenic, colorless to pale yellow, clear to slightly opalescent solution that must be diluted prior to administration in 0.9% Sodium Chloride Injection	Intravenous infusion	Enzyme Replacement Agents	N.A.
1456	Th1086	Interferon Alfa-2B, Recombinant	CDLPQTHSLGSRRTLMLLAQ Full view	165	Ib	Immunological	INTRON® A	Merck	Powder or solution	Intramuscular, Subcutaneous, Intralesional, or Intravenous injection	Immunosuppressive Agents	Granulocyte colony-stimulating factor receptor,Neutrophil elastase, Coagulation factor X,Coagulation factor XI,Coagulation factor VII,Coagulation factor VIII,Prothrombin,Prolow-density lipoprotein receptor-related protein 1,Vitamin K-dependent gamma-carboxylase, Platelet-derived growth factor receptor beta,Platelet-derived growth factor receptor alpha,Alpha-2-macroglobulin
1460	Th1087	Oxytocin	CYIQNCPLG Full view	9	Ib	Hormonal	Pitocin	JHP Pharmaceuticals	Sterile, clear, colorless aqueous solution of synthetic oxytocin	Intravenous infusion	Oxytocics, Anti-tocolytic Agents and Labor Induction Agents	Interferon alpha/beta receptor 2,Interferon alpha/beta receptor 1, Globotriaosylceramide
1465	Th1089	Palivizumab	VH region: QVTLRESG< Full view	120	IIIa	Infectious	Synagis	MedImmune	Sterile, preservative-free liquid solution	Intramuscular injection	Antiviral Agents	N.A.
1468	Th1091	Bevacizumab	DIQMTQSPSSLSASVGDRVT Full view	214	IIa	Cardiac	Avastin	Genentech	Slightly opalescent, colorless to pale brown, sterile, pH 6.2 solution for intravenous infusion	Intravenous infusion	Angiogenesis Inhibitors	Interleukin-2 receptor subunit alpha,Interleukin-2 receptor subunit beta,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
1473	Th1093	Eculizumab	N.A. Full view	0	Ia	Haemetological	Soliris	Alexion, Inc	Sterile, clear, colorless, preservative-free 10 mg/mL solution for intravenous infusion	N.A.	N.A.	Complement C5
1475	Th1095	Ranibizumab	Light Chain SASQDISN Full view	447	IIa	Hematological/Eye Disorder	Lucentis	Genentech	Sterile, colorless to pale yellow solution	Intravitreal injection	Ophthalmics	Vascular endothelial growth factor A
1476	Th1096	Idursulfase	SETQANSTTDALNVLLIIVD Full view	525	Ia	Metabolic	Elaprase	SHIRE	Sterile, nonpyrogenic clear to slightly opalescent, colorless solution that must be diluted prior to administration in 0.9% Sodium Chloride Injection, USP	Intravenous infusion	Enzyme Replacement Agents	Dermatan sulfate,Heparan sulfate,Perilipin-3
1482	Th1100	Pramlintide	KCNTATCATQRLANFLVHSS Full view	37	Ia	Hormonal/Metabolic	Symlin	Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca)	Clear, isotonic, sterile solution	Subcutaneous injection	N.A.	Calcitonin receptor,Receptor activity-modifying protein 1,Receptor activity-modifying protein 2,Receptor activity-modifying protein 3
1494	Th1101	Galsulfase	SGAGASRPPHLVFLLADDLG Full view	497	Ia	Metabolic	Naglazyme	BioMarin	Sterile, nonpyrogenic, colorless to pale yellow, clear to slightly opalescent solution that must be diluted with 0.9% Sodium Chloride Injection, USP, prior to administration	Intravenous infusion	Enzyme Replacement Agents	Dermatan sulfate,Perilipin-3
1502	Th1105	Insulin Aspart	A chain: GIVEQCCTSIC Full view	51	Ia	Hormonal/Metabolic	NovoLog	Novo Nordisk	Sterile, aqueous, clear, and colorless solution	Subcutaneous injection, Intravenous injection	Hypoglycemic Agents and Antidiabetic Agents	Insulin receptor
1511	Th1106	Insulin Detemir	A chain: GIVEQCCTSIC Full view	51	Ia	Hormonal/Metabolic	LEVEMIR	Novo Nordisk	Clear, colorless, aqueous, neutral sterile solution	Subcutaneous injection	Antidiabetic Agents	Insulin receptor
1520	Th1107	Insulin Glulisine	A chain: GIVEQCCTSIC Full view	51	Ib	Hormonal/Metabolic	APIDRA	sanofi-aventis	Sterile, aqueous, clear, and colorless solution	N.A.	Antidiabetic Agents	Insulin receptor
1529	Th1108	Pegaptanib	N.A. Full view	0	IIa	Hematological/Eye Disorder	Macugen	Gilead Sciences	Sterile, aqueous solution containing pegaptanib sodium for intravitreous injection	Intravitreal injection	Intended for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.	N.A.
1534	Th1113	Glatiramer Acetate	EAYKAAEKAYAAKEAAKEAA Full view	52	IIa	Neurological Disorder	Copaxone	Teva Pharmaceutical Industries	Clear, colorless to slightly yellow, sterile, nonpyrogenic solution	Subcutaneous injection	N.A.	N.A.
1548	Th1117	Ipilimumab	Heavy chain: QVQLVES Full view	663	IIIc	Cancer	YERVOY	Bristol-Myers Squibb	Sterile, preservative-free, clear to slightly opalescent, colorless to pale-yellow solution	N.A.	Antineoplastic Agents and Monoclonal antibodies	Cytotoxic T-lymphocyte protein 4
1550	Th1119	Tocilizumab	N.A. Full view	0	IIa	Immunological	ACTEMRA	Genentech	Sterile, preservative-free solution, colorless to pale yellow liquid, with a pH of about 6.5	Intravenous infusion, Subcutaneous injection	N.A.	Interleukin-6 receptor subunit alpha
1556	Th1120	Teriparatide	Parathyroid hormone Full view	34	Ib	Osteological	Forteo	Eli Lilly and Company	Sterile, colorless, clear, isotonic solution	Subcutaneous injection	Bone Density Conservation Agents	Parathyroid hormone/parathyroid hormone-related peptide receptor
1570	Th1123	Denosumab	Heavy chain EVQLLESG Full view	664	IIIc	Osteological	Xgeva	Amgen.	Sterile, preservative-free, clear, colorless to pale yellow solution	N.A.	Bone Density Conservation Agents and Monoclonal antibodies	Tumor necrosis factor ligand superfamily member 11
1571	Th1123	Denosumab	Heavy chain EVQLLESG Full view	664	IIIc	Osteological	Prolia	Amgen.	Sterile, preservative-free, clear, colorless to pale yellow solution	N.A.	Bone Density Conservation Agents and Monoclonal antibodies	Tumor necrosis factor ligand superfamily member 11
1576	Th1124	Liraglutide	HAEGTFTSDVSSYLEGQAAK Full view	33	Ib	Hormonal	Saxenda	Novo Nordisk	Clear, colorless solution	Subcutaneous injection	N.A.	Glucagon-like peptide 1 receptor
1577	Th1124	Liraglutide	HAEGTFTSDVSSYLEGQAAK Full view	33	Ib	Hormonal	Victoza	Novo Nordisk	Clear, colorless solution.	Subcutaneous injection	N.A.	Glucagon-like peptide 1 receptor
1583	Th1125	Golimumab	N.A. Full view	0	IIb	Immunological	Simponi Injection	N.A.	Clear to slightly opalescent, colorless to light yellow solution	Subcutaneous injection	Antipsoriatic Agents and Monoclonal antibodies and TNF inhibitor	Tumor necrosis factor
1584	Th1125	Golimumab	N.A. Full view	0	IIb	Immunological	Simponi Injection	N.A.	Sterile concentrated solution of the golimumab antibody	Intravenous infusion	Antipsoriatic Agents and Monoclonal antibodies and TNF inhibitor	Tumor necrosis factor
1600	Th1127	Buserelin	N.A. Full view	0	IIIc	Cancer/Hormonal	Suprecur (Nasal Spray Solution)	Sanofi-Aventis	150 micrograms Nasal Spray Solution	Nasal spray	N.A.	Lutropin-choriogonadotropic hormone receptor,Gonadotropin-releasing hormone receptor
1615	Th1133	Aflibercept	SDTGRPFVEMYSEIPEIIHM Full view	431	Ib	Cancer	Eylea	Regeneron Pharmaceuticals	Sterile, clear, and colorless to pale yellow solution.	Intravitreal injection	Antineoplastic Agents and Ophthalmics	Vascular endothelial growth factor A,Placenta growth factor,Vascular endothelial growth factor B
1616	Th1133	Aflibercept	SDTGRPFVEMYSEIPEIIHM Full view	431	Ib	Cancer	Zaltrap	Sanofi and Regeneron Pharmaceuticals, Inc.	Sterile, clear, colorless to pale yellow, non-pyrogenic, preservative-free, solution.	Intravenous infusion	Antineoplastic Agents and Ophthalmics	Vascular endothelial growth factor A,Placenta growth factor,Vascular endothelial growth factor B
1622	Th1135	Ocriplasmin	Truncated heavy chai Full view	251	Ic	Eye Disorder	Jetrea	ThromboGenics NV	Sterile, clear and colorless solution with no preservatives	Intravitreal injection	Ophthalmics	Fibronectin,Alpha-2-macroglobulin,Alpha-2-antiplasmin
1628	Th1139	Certolizumab Pegol	Light chain: DIQMTQS Full view	443	IIb	Immunologcal	Cimzia	UCB	Sterile, white, lyophilized powder for solution or as a sterile, solution in a single-use prefilled 1 mL glass syringe	Subcutaneous injection	TNF inhibitor	Tumor necrosis factor
1635	Th1141	Epoetin Zeta	APPRLICDSRVLERYLLEAK Full view	166	Ib	Cancer	Retacrit	Norbitec	solution for injection	N.A.	N.A.	Erythropoietin receptor
1654	Th1150	Secukinumab	Secukinumab Heavy Ch Full view	672	IIa	Immunological	Cosentyx	Novartis Pharmaceuticals Corporation	Sterile, preservative-free, clear to slightly opalescent, colorless to slightly yellow solution.	Subcutaneous injection	Inhibitor	IL-17A cytokine
1667	Th1158	Aprotinin	RPDFCLEPPYTGPCKARIIR Full view	58	IIa	Immunological	Trasylol	Bayer Pharmaceuticals	Clear, colorless, sterile isotonic solution	Intravenous administration	N.A.	Trypsin-1, Chymotrypsinogen B, Plasminogen, Kallikrein-!
1674	Th1161	Albiglutide	HGEGTFTSDVSSYLEGQAAK Full view	645	Ib	Hormonal disorders	Eperzan	Glaxosmithkline Inc	Powder for Solution	Subcutaneous	Drugs used in diabetes; alimentary tract and metabolism; blood glucose lowering drugs, excl. insulins.	Glucagon-like peptide 1 receptor
1676	Th1161	Albiglutide	HGEGTFTSDVSSYLEGQAAK Full view	645	Ib	Hormonal disorders	Tanzeum	Glaxo Smith Kline Llc	Injection, Powder, Lyophilized, for Solution	Subcutaneous	Drugs used in diabetes; alimentary tract and metabolism; blood glucose lowering drugs, excl. insulins.	Glucagon-like peptide 1 receptor
1678	Th1162	Alirocumab	NA Full view	0	Ic	Metabolic/Cardiac	Praluent	Sanofi Aventis U.S. Llc	Injection, Solution	Subcutaneous	N.A.	Proprotein convertase subtilisin/kexin type 9
1679	Th1162	Alirocumab	NA Full view	0	Ic	Metabolic/Cardiac	Praluent	Sanofi Aventis Canada Inc	Solution	Subcutaneous	N.A.	Proprotein convertase subtilisin/kexin type 10
1680	Th1162	Alirocumab	NA Full view	0	Ic	Metabolic/Cardiac	Praluent	Sanofi Aventis Canada Inc	Solution	Subcutaneous	N.A.	Proprotein convertase subtilisin/kexin type 11
1681	Th1162	Alirocumab	NA Full view	0	Ic	Metabolic/Cardiac	Praluent	Sanofi Aventis U.S. Llc	Injection, Solution	Subcutaneous	N.A.	Proprotein convertase subtilisin/kexin type 14
1684	Th1164	Antithrombin Alfa	NA Full view	0	Ia	Hematological Disorders	Atryn	Gtc Biotherapeutics, Inc.	Injection, Powder, Lyophilized, for Solution	Intravenous	NA	NA
1685	Th1164	Antithrombin Alfa	NA Full view	0	Ia	Hematological Disorders	Atryn	R Evo Bioloigics, Inc.	Injection, Powder, Lyophilized, for Solution	Intravenous	NA	NA
1688	Th1165	Antithrombin III human	NA Full view	0	Ia	Hematological Disorders	Thrombate III	Grifols Therapeutics Inc	Powder for Solution	NA	NA	NA
1691	Th1165	Antithrombin III human	NA Full view	0	Ia	Hematological Disorders	Thrombate III Pws IV 1000iu/vial	Miles Inc. Pharmaceutical Division	Powder for Solution	NA	NA	NA
1694	Th1166	Asfotase Alfa	LVPEKEKDPKYWRDQAQETL Full view	726	Ia	Genetic Disorders	Strensiq	Alexion Pharma Ghbh	Solution	Subcutaneous	Enzymes Alimentary Tract and Metabolism	Sphingosine 1-phosphate receptor 1; Pyrophosphate